Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial.
Hossein BehzadSina MashayekhiHila AshamParvin SarbakhshTaher Entezari-MalekiPublished in: Journal of cardiovascular and thoracic research (2024)
The results of this trial could not express the advantages of acute pretreatment with empagliflozin in preventing PCI-related myocardial injury.
Keyphrases